Related Experiment Video
Updated: May 3, 2026

10:23
Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice
Published on: December 1, 2017
16.6K
Animal Models of Hunner-Type Interstitial Cystitis
1Department of Urology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Summary
Interstitial cystitis/bladder pain syndrome (IC/BPS) research benefits from novel animal models. The URO-OVA experimental autoimmune cystitis (EAC) model effectively mimics Hunner-type IC (HIC), aiding in understanding immune-mediated bladder inflammation and pain.
Area of Science:
- Urology
- Immunology
- Pathology
Background:
- Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic bladder condition with undefined etiology.
- IC/BPS presents as Hunner-type IC (HIC) or bladder pain syndrome (BPS), with distinct pathologies but overlapping symptoms.
- HIC is increasingly recognized as an immune-mediated inflammatory disease, with autoimmunity playing a significant role.
Purpose of the Study:
- To review immune-mediated inflammation and autoimmunity in IC/BPS.
- To discuss experimental autoimmune cystitis (EAC) models for HIC research.
- To highlight the URO-OVA model as a novel transgenic EAC model that accurately replicates HIC.
Main Methods:
- Overview of existing literature on IC/BPS pathogenesis and animal models.
- Focus on the development and characteristics of the URO-OVA transgenic EAC model.
- Evaluation of the URO-OVA model's ability to mimic HIC clinical and pathological features.
Main Results:
- The URO-OVA model exhibits chronic bladder inflammation, pelvic/bladder pain, and urinary dysfunction characteristic of HIC.
- This model shows therapeutic responses to dimethyl sulfoxide (DMSO) and inhibitors of Toll-like receptor 4 (TLR4), mitogen-activated protein (MAP) kinase, and interferon-gamma (IFN-γ).
- The URO-OVA model demonstrates stability and reproducibility in research settings.
Conclusions:
- The URO-OVA model serves as a valuable and unique tool for HIC research.
- It effectively incorporates immune and autoimmune components relevant to HIC pathophysiology.
- This model facilitates mechanistic studies and the development of targeted therapies for HIC.

